Invitation for Coloplast's Q1 2021/22 earnings release conference call
Tuesday, 25 January 2022
at 15.00 - 16.00 CET
In connection with the publication of Coloplast's financial statements for Q1 2021/22 the company will host a conference call to present financial statements and answer questions from investors and financial analysts.
A presentation will be available on our website approximately 1 hour before the conference call.
Please note that the webcast of the conference call will be available during and after the event.
Coloplast will be represented by
Kristian Villumsen - President & CEO
Anders Lonning-Skovgaard - Executive Vice President, CFO
Ellen Bjurgert - Vice President, Investor Relations
Aleksandra Dimovska - Senior Manager, Investor Relations
Webcast
Any participants who do not wish to actively participate in the question & answer session, please access the conference call as a webcast directly by clicking here:
For analysts and any participants wishing to actively participate in the question & answer session please call and identify yourself to the operator a few minutes before start time using one of the following telephone numbers:
Coloplast will be available on individual phone lines after the conference call for further questions.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Coloplast A/S published this content on 04 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 January 2022 12:48:07 UTC.
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows:
- hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.;
- ostomy care products (36.8%): bags and equipment used following intestinal operations;
- wound care and skincare products (11.9%): wound dressings, bandages, creams and gels;
- voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc.
Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
COLOPLAST A/S 
